Validation of red cell distribution width as a COVID-19 severity screening tool

AIM: The aim of this study is the predictive validation of red cell distribution width (RDW) in COVID-19 patients. METHOD: In total, 331 COVID-19 patients were classified as ‘severe’ and ‘nonsevere’ groups based on the WHO standard criteria. The levels of RDW standard deviation (SD) were evaluated a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pouladzadeh, Mandana, Safdarian, Mehdi, Choghakabodi, Parastoo Moradi, Amini, Fatemeh, Sokooti, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056748/
https://www.ncbi.nlm.nih.gov/pubmed/34254030
http://dx.doi.org/10.2144/fsoa-2020-0199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056748/
https://www.ncbi.nlm.nih.gov/pubmed/34254030
http://dx.doi.org/10.2144/fsoa-2020-0199

Ejemplares similares